Showing results (1331-1340 of 1,799) with videos related to
Sort By:
Pageof 180
Mabs|December 20, 2013
Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometryNatalie J Thompson, Linda J A Hendriks, John de Kruif, et al.Mabs|April 7, 2016
A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cellsXiaodong Xiao, Yan Chen, Reena Varkey, et al.Mabs|April 7, 2016
Evaluating imbalances of adverse events during biosimilar developmentAlicia M Vana, Amy W Freyman, Steven D Reich, et al.Mabs|March 12, 2016
Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitorsSilvia Calpe, Ana C P Correia, Maria Del Carmen Sancho-Serra, et al.Mabs|July 26, 2013
Therapeutic antibodies and infectious diseases, Tours, France, November 20-22, 2012Guillaume Desoubeaux, Arnaud Daguet, Hervé WatierMabs|July 26, 2013
LC-MS characterization and purity assessment of a prototype bispecific antibodyR Jeremy Woods, Michael Hongwei Xie, Thomas Spreter Von Kreudenstein, et al.Mabs|July 26, 2013
Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragmentGisela Esquerda-Canals, Joaquim Marti, Geovanny Rivera-Hernández, et al.Mabs|March 2, 2012
Influence of improved FcRn binding on the subcutaneous bioavailability of monoclonal antibodies in cynomolgus monkeysAmita Datta-Mannan, Derrick R Witcher, Jirong Lu, et al.Mabs|March 2, 2012
Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation systemGang Yin, Eudean D Garces, Junhao Yang, et al.Mabs|March 29, 2012
Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administrationYanan Zheng, Devin B Tesar, Lisa Benincosa, et al.Pageof 180